Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin

被引:49
|
作者
Shlezinger, Mor [1 ,2 ]
Coppenhagen-Glazer, Shunit [2 ]
Gelman, Daniel [2 ]
Beyth, Nurit [1 ]
Hazan, Ronen [2 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Prosthodont, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Fac Dent Sci, Hadassah Sch Dent Med, IL-91120 Jerusalem, Israel
来源
VIRUSES-BASEL | 2019年 / 11卷 / 10期
基金
以色列科学基金会;
关键词
phage therapy; Enterococcus faecalis (VRE); vancomycin; phage EFLK1; phage-antibiotic synergy (PAS); BACTERIOPHAGE; BIOFILM; ANTIBIOTICS; BIOCONTROL; MECHANISMS; EVOLUTION; EFFICACY; ECOLOGY;
D O I
10.3390/v11100954
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Currently, effective options are needed to fight vancomycin-resistant Enterococcus faecalis (VRE). The present study shows that combinations of phage and vancomycin are highly efficient against VRE, despite being resistant to the antibiotic. Vancomycin-phage EFLK1 (anti-E. faecalis phage) synergy was assessed against VRE planktonic and biofilm cultures. The effect of the combined treatment on VRE biofilms was determined by evaluating the viable counts and biomass and then visualized using scanning electron microscopy (SEM). The cell wall peptidoglycan was stained after phage treatment, visualized by confocal microscopy and quantified by fluorescence activated cell sorting (FACS) analysis. The combined treatment was synergistically effective compared to treatment with phage or antibiotic alone, both in planktonic and biofilm cultures. Confocal microscopy and FACS analysis showed that fluorescence intensity of phage-treated bacteria increased eight-fold, suggesting a change in the peptidoglycan of the cell wall. Our results indicate that with combined treatment, VRE strains are not more problematic than sensitive strains and thus give hope in the continuous struggle against the current emergence of multidrug resistant pathogens.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients
    Roghmann, MC
    Fink, JC
    Polish, L
    Maker, T
    Brewrink, J
    Morris, JG
    Light, PD
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (02) : 254 - 257
  • [22] Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
    AbdelKhalek, Ahmed
    Abutaleb, Nader S.
    Mohammad, Haroon
    Seleem, Mohamed N.
    PLOS ONE, 2018, 13 (06):
  • [23] Vancomycin-resistant enterococci carriage in an acute Irish hospital
    Whelton, E.
    Lynch, C.
    O'Reilly, B.
    Corcoran, G. D.
    Cryan, B.
    Keane, S. M.
    Sleator, R. D.
    Lucey, B.
    JOURNAL OF HOSPITAL INFECTION, 2016, 93 (02) : 175 - 180
  • [24] Hospital effluent constitutes a source of vancomycin-resistant enterococci
    Nunez, Lidia
    Tornello, Carina
    Puentes, Noel
    Espigares, Elena
    Moreno, Elena
    Espigares, Miguel
    Moretton, Juan
    ARS PHARMACEUTICA, 2016, 57 (03) : 121 - 126
  • [25] Vancomycin-resistant Enterococci: What Treatment Options are available?
    Mutters, N. T.
    Werner, G.
    Tacconelli, E.
    Mischnik, A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (01) : 42 - +
  • [26] Design and Synthesis of Pyrophosphate-Targeting Vancomycin Derivatives for Combating Vancomycin-Resistant Enterococci
    Guan, Dongliang
    Chen, Feifei
    Faridoon
    Liu, Junjie
    Li, Jian
    Lan, Lefu
    Huang, Wei
    CHEMMEDCHEM, 2018, 13 (16) : 1644 - 1657
  • [27] Risk of vancomycin-resistant enterococci in patients with primary sclerosing cholangitis treated with oral vancomycin
    Shah, A.
    Pakneshan, S.
    Macdonald, G. A.
    Martin, N.
    Callaghan, G.
    Burger, D.
    Tallis, C.
    Chao, C. Y.
    Morrison, M.
    Stuart, K. A.
    Holtmann, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 259 - 259
  • [28] Emergence of vancomycin-resistant enterococci from vancomycin-susceptible enterococci in hospitalized patients under antimicrobial therapy
    Janice, Jessin
    Wagner, Theresa Maria
    Olsen, Karina
    Hegstad, Joachim
    Hegstad, Kristin
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 36 : 116 - 122
  • [29] In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
    Tong, Jiepeng
    Jiang, Yiheng
    Xu, Hao
    Jin, Xuehang
    Zhang, Li
    Ying, Shuaibing
    Yu, Wei
    Qiu, Yunqing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3049 - 3055
  • [30] Therapeutic Options for Infections due to vanB Genotype Vancomycin-Resistant Enterococci
    Riccardi, Niccolo
    Monticelli, Jacopo
    Antonello, Roberta Maria
    Di Lallo, Gustavo
    Frezza, Domenico
    Luzzati, Roberto
    Di Bella, Stefano
    MICROBIAL DRUG RESISTANCE, 2021, 27 (04) : 536 - 545